Competition Act claim alleges that Canadians are being overcharged for prescription drugs Competition Act claim alleges that Canadians are being overcharged for prescription drugs
  • The Firm
  • Our Litigation
  • Our News
  • Contact Us
  • The Firm
  • Our Litigation
  • Our News
  • Contact Us

November 2014

Competition Act claim alleges that Canadians are being overcharged for prescription drugs

Morganti Legal and McKenzie Lake Lawyers LLP, are representing Canadian pharmacies and consumers that allege that Pfizer Canada Inc abused the Canadian patent system in order to obtain exclusive rights in Canada to sell the pharmaceutical drug pregabalin sold under the trade name Lyrica. Pfizer’s activities resulted in it enjoying 100% of the Canadian market…

Read More

Recent News

  • MORGANTI & CO., P.C. x KIM SPENCER MCPHEE BARRISTERS P.C.
  • Quebec courts recognize investors’ allegations of insiders manipulating stock prices
  • “You can’t handle the truth!”
  • Investment Banks’ Responsibilities: Court of Appeal for Ontario endorses claim
  • Former Newstrike Brands Ltd. investors lodge claim against HEXO CORP.
Morganti & CO., P.L.C. (Michigan, United States)

Disclaimer / Terms of Use
Morganti & CO., P.C. (Ontario, Canada)
Register

    For the shares purchased during the identified "class period", those shares are automatically considered to be included within the proceeding. For shares purchased outside of the identified "class period", those are not automatically included and you may be required to retain your own lawyer.

    We welcome you to complete the below form so you can receive future updates about the proceeding. If you invested more than $100,000, in the particular investment, please complete the form and we will contact you within the near future.